Perfluoroalkyl acids and related chemistries - Toxicokinetics and modes of action

Toxicological Sciences

Volumn 102, Issue 1, 2008, Pages 3-14

  Andersen, Melvin E ^a   Butenhoff, John L ^b   Chang, Shu Ching ^b   Farrar, David G ^c   Kennedy Jr , Gerald L ^d   Lau, Christopher ^e   Olsen, Geary W ^b   Seed, Jennifer ^f   Wallace, Kendall B ^g  

^a HAMNER INSTITUTES FOR HEALTH SCIENCES   (United States)

^b 3M COMPANY   (United States)

^c Ineos Manufacturing Scotland Limited   (United Kingdom)

^d DUPONT COMPANY   (United States)

^e U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^f U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^g UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Modes of action; Perfluoroalkyl acids; Toxicokinetics

Indexed keywords

ALCOHOL; CARBOXYLIC ACID DERIVATIVE; CELL NUCLEUS RECEPTOR; INDUSTRIAL CHEMICAL; PERFLUORO COMPOUND; PERFLUOROALKYL ACID DERIVATIVE; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

CARCINOGENESIS; CHEMICAL STRUCTURE; DOSIMETRY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL IMPACT; ENVIRONMENTAL PROTECTION; HEALTH HAZARD; HUMAN; IMMUNOTOXICITY; LEYDIG CELL; LIVER TOXICITY; NONHUMAN; OCCUPATIONAL EXPOSURE; PANCREAS CANCER; REPRODUCTIVE TOXICITY; REVIEW; RISK ASSESSMENT; STRUCTURE ANALYSIS; TERATOGENICITY; TESTIS CANCER; TISSUE DISTRIBUTION; TOXICOKINETICS; TOXICOLOGY; WILDLIFE;

ANIMALS; CARBOXYLIC ACIDS; CELL NUCLEUS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL POLLUTANTS; FLUOROCARBONS; HUMANS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SPECIES SPECIFICITY; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONIC ACIDS; TOXICITY TESTS;

ANIMALIA;

EID: 39149141030     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfm270     Document Type: Review

References (60)

1. Abbott, B. D., Wolf, C. J., Schmid, J. E, Das, K. P., Zehr, R. D., Helfant, L., Nakayama, S., Lindstrom, A. B., Strynar, M. J., and Lau, C. S. (2007). Perfluorooctanoic acid (PFOA)-induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha (PPAR {alpha}). Toxicol. Sci. 98, 571-581.
2. Alexander, B. H., Olsen, G. W., Burris, J. M., Mandel, J. H., and Mandel, J. S. (2003). Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility. Occup. Environ. Med. 60, 722-729.
3. Andersen, M. E., Birnbaum, L. S., Barton, H. A., and Eklund, C. R. (1997). Regional hepatic CYP1A1 and CYP1A2 induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin evaluated with a multicompartment geometric model of hepatic zonation. Toxicol. Appl. Pharmacol. 144, 145-155.
4. Andersen, M. E., Clewell, H. J., 3rd, Tan, Y. M., Butenhoff, J. L., and Olsen, G. W. (2006). Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeys - Probing the determinants of long plasma half-lives. Toxicology 227, 156-164.
5. Apelberg, B. J., Goldman, L. R., Calafat, A. M., Herbstman, J. B., Kuklenyik, Z., Heidler, J., Needham, L. L., Halden, R. U., and Witter, F. R. (2007b). Determinants of fetal exposure to polyfluoroalkyl compounds in Baltimore, Maryland. Environ. Sci. Technol. 41, 3891-3897.
6. Apelberg, B. J., Witter, F. R., Herbstman, J. B., Calafat, A. M., Halden, R. U., Needham, L. L., and Goldman, L. R. (2007a). Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ. Health PerspecH. doi:10.1289/ehp.10334. Available at: http://dx.doi.org/. Online 31 July 2007.
7. Butenhoff, J. L., Kennedy, G. L., Jr, Hinderliter, P. M., Lieder, P. H., Jung, R., Hansen, K. J., Gorman, G. S., Noker P. E., and Thomford, P. J. (2004a). Pharmacokinetics of perfluorooctanoate in cynomolgus monkeys. Toxicol. Sci. 82, 394-406.
8. Butenhoff, J. L., Kennedy, G. L., Jr, Frame, S. R., O'Connor, J. C., and York, R. G. (2004b). The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat. Toxicology 196, 95-116.
9. Calafat, A. M., Kuklenyik, Z., Reidy J. A., Caudill, S. P., Tully, J. S., and Needham, L. L. (2007a). Serum concentrations of 11 polyfluoroalkyl compounds in the u.s. population: Data from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environ. Sci. Technol. 41, 2237-2242.
10. Calafat, A., Wong, L. Y., Kuklenylk, Z., Reidy, J. A., and Needham, L. L. (2007b). Polyfluoroalkyl chemicals in the U.S. population: Data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons to NHANES 1999-2000. Environ. Health Perspect. doi:10.1289/ehp.10598 [epub ahead of print].
11. Case, M. T., York, R. G., and Christian, M. S. (2001). Rat and rabbit oral developmental toxicology studies with two perfluorinated compounds. Int. J. Toxicol. 20, 101-109.
12. Cheung, C., Akiyama, T. E., Ward, J. M., Nicol, C. J., Feigenbaum, L., Vinson, C., and Gonzalez, F. J. (2004). Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha. Cancer Res. 64, 3849-3854.
13. Cohen, S. M., Meek, M. E., Klaunig, J. E., Patton, D. E., and Fenner-Crisp, P. A. (2003). The human relevance of information on carcinogenic modes of action: Overview. Crit. Rev. Toxicol. 33 581-589.
14. Ehresman, D. J., Froelich, J. W., Olsen, G. W., Chang, S.-C., and Butenhoff, J. L. (2007). Comparison of whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals. Environ. Res. 103, 176-184.
15. Emmett, E. A., Shofer, F. S., Zhang, H., Freeman, D., Desai, C., and Shaw, L. M. (2006b). Community exposure to perfluorooctanoate: Relationships between serum concentrations and exposure sources. J. Occup. Environ. Med. 48, 759-770.
16. Emmett, E. A., Zhang, N., Shofer, F. S., Freeman, D., Rodway, N. V., Desai, C., and Shaw, L. M. (2006a). Community exposure to perfluorooctanoate: Relationships between serum levels and certain health parameters. J. Occup. Environ. Med. 48, 771-779.
17. Fei, C., McLaughlin, J. K., Tarone, R. E. and Olsen, J. (2007). Perfluorinated chemicals and fetal growth: A study within the Danish National Birth Cohort. Environ. Health Perspect. doi:10.1289/ ehp.10506
18. Fewell, Z., Smith, G. D., and Sterne, J. A., C. (2007). The impact of residual and unmeasured confounding in episdemiologic studies: A simulation study. Am. J. Epidemiol. 1669, 646-655.
19. Giesy, J. P., and Kannan, K. (2001), Global distribution of perfluorooctane sulfonate in wildlife. Environ. Sci. Technol. 35, 1339-1342.
20. Grasty, R. C., Bjork, J. A., Wallace, K. B., Wolf, D. C., Lau, C. S., and Rogers, J. M. (2005). Effects of prenatal perfluorooctana sulfonate (PFOSP) exposure on lung maturation in the perinatal rat. Birth Defects Res. B Dev. Reprod. Toxicol. 74, 405-416.
21. Grasty, R. C., Wolf, D. C., Grey, B. E., Lau, C. S., and Rogers, J. M. (2003). Prenatal window of susceptibility to perfluorooctane sulfonate-induced neonatal mortality in the Sprague-Dawley rat. Birth Defects Res. B Dev. Reprod. Toxicol. 68, 465-471.
22. Grice, M. M., Alexander, B. H., Hoffbeck, R., and Kampa, D. M. (2007). Self-reported medical conditions in perfluorooctanesulfonyl fluoride manufacturing workers. J. Occup. Environ. Med. 49, 722-729.
23. Hansen, K. J., Clemen, L. A., Ellefson, M. E., and Johnson, H. O. (2001). Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices. Environ. Sci. Technol. 35, 766-770.
24. Hundley, S. G., Sarrif, A. M., and Kennedy, G. L. (2006). Absorption, distribution, and excretion of ammonium perfluorooctanoate (APFO) after oral administration to various species. Drug Chem. Toxicol. 29 137-145.
25. Katakura, M., Kudo, N., Tsuda, T., Hibino, Y., Mitsumoto, A., and Kawashima, Y. (2007). Rat organic anion transporter 3 and organic anion transporting polypeptide 1 mediate perfluorooctanoic acid transport. J. Health Sci. 53, 77-83.
26. Kennedy, G. L., Jr., Butenhoff, J. L., Olsen, G. W., O'Connor, J. C., Seacat, A. M., Perkins, R. G., Biegel, L. B., Murphy, S. R., and Farrar, D. G. (2004). The toxicology of perfluorooctanoate. Crit. Rev. Toxicol. 34, 351-384.
27. Klaunig, J. E., Babich, M. A., Baetcke, K. P., Cook, J. C., Corton, J. C., David, R. M., DeLuca, J. G., Lai, D. Y., McKee, R. H., Peters, J. M., et al. (2003). PPARalpha agonist-induced rodent tumors: Modes of action and human relevance. Crit. Rev. Toxicol. 33, 655-680.
28. Kudo, N., Bandai, N., Suzuki, E., Katakura, M., and Kawashima, Y. (2000). Induction by perfluorinated fatty acids with diffierent carbon chain length of peroxisomal beta-oxidation in the liver of rats. Chem. Biol. Interact. 124, 119-132.
29. Kudo, N., Katakura, M., Sato, Y., and Kawashima, Y. (2002). Sex hormone-regulated renal transport of perfluorooctanoic acid. Chem. Biol. Interact. 139, 301-316.
30. Kudo, N., and Kawashima, Y. (2003). Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals. J. Toxicol. Sci. 28, 49-57.
31. Kudo, N., Sakai, A., Mitsumoto, A., Hibino, Y., Tsuda, T., and Kawashima, Y. (2007). Tissue distribution and hepatic subcellular distribution of perfluorooctanoic Acid at low dose are different from those at high dose in rats. Biol. Pharm. Bull. 30, 1535-1540; JST.JSTAGE/bpb/30.1535 [pii].
32. Kudo, N., Suzuki, E., Katakura, M., Ohmori, K., Noshiro, R., and Kawashima, Y. (2001). Comparison of the elimination between perfluolinated fatty acids with different carbon chain length in rats. Chem. Biol. Interact. 134, 203-216.
33. Kudo, N., Suzuki-Nakajima, E., Mitsumoto, A, and Kawashima, Y. (2006). Responses of the liver to perfluorinated fatty acids with different carbon chain length in male and female mice: In relation to induction of hepatomegaly, peroxisomal beta-oxidation and microsomal 1-acylglycerophosphocholine acyltransferase. Biol. Pharm. Bull. 29, 1952-1957.
34. Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A., and Seed, J. (2007). Perfluoroalkyl acids: A review of monitoring and toxicological findings. Toxicol. Sci. 99, 366-394. doi:l0.1093/toxsci/kfm128.
35. Lau, C., Butenhoff, J. L., and Rogers, J. M. (2004). The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol. Appl. Pharmacol. 198, 231-241.
36. Lau, C., Thibodeaux, J. R., Hanson, R. G., Narotsky, M. G. Rogers, J. M., Lindstrom, A. B., and Strynar, M. J. (2006). Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. Toxicol. Sci. 90, 510-518.
37. Lau, C., Thibodeaux, J. R., Hanson, R. G., Rogers, J. M., Grey, B. E., Stanton, M. E., Butenhoff, J. L., and Stevenson, L. A. (2003). Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: Postnatal evaluation. Toxicol. Sci. 74, 382-392.
38. Leonard, R. C., Kreckmann, K. H., Sakr, C. J., and Symons, J. M. (2007). Retrospective Cohort Mortality Study of Workers in a Polymer Production Plant Including a Reference Population of Regional Workers. Ann Epidemiol. (Epub ahead of print]
39. Luebker, D. J., Case, M. T., York, R. G., Moore, J. A., Hansen, K. J., and Butenhoff, J. L. (2005a). Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats. Toxicology 215, 126-148.
40. Luebker, D. J., York, R. G., Hansen, K. J., Moore, J. A., and Butenhoff, J. L. (2005b). Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: Dose-response, and biochemical and pharmacokinetic parameters. Toxicology 215 149-169.
41. Midasch, O., Drexler, H., Hart, N., Beckmann, M. W., and Angerer, J. (2007). Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: A pilot study. Int. Arch. Occup. Environ. Health 80, 643-648.
42. Morimura, K., Cheung, C., Ward, J. M., Reddy, J. K., and Gonzalez, F. J. (2006). Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis. Carcinogenesis 27, 1074-1080.
43. Ohmori, K., Kudo, N., Katayama, K., and Kawashima, Y. (2003). Comparison of the toxicokinetics between perfluorocarboxylic acids with different carbon chain length. Toxicology 184, 135-140.
44. Olsen, G. W., Burris, J. M., Ehresman, D. J., Froehlich, J. W., Seacat, A. M., Butenhoff, J. L., and Zobel, L. R. (2007a). Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ. Health Perspect. 115, 1298-1305.
45. Olsen, G. W., Church, T. R., Miller, J. P., Burris, J. M., Hansen, K. J., Lundberg, I. K., Armitage, I. B., Herron, R. M., Medhdizadehkashi, Z., Nobiletti, J. B., et al. (2003a). Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. Environ. Health Perspect. 111, 1892-1901.
46. Olsen, G. W., Logan, P. W., Hansen, K. J., Simpson, C. A., Burris, J. M., Burlew, M. M., Vorarath, P. P., Venkateswedu, P., Schumpert, J. C., and Mandel, J. H. (2003b). An occupational exposure assessment of a perfluorooctanesulfonyl fluoride production site: Biomonitoring. Am. Ind. Hyg. Assoc. J. 64, 651-659.
47. Olsen, G. W., Mair, D. C., Reagen, W. K., Ellefson, M. E., Ehresman, D. J., Butenhoff, J. L., and Zobel, L. R. (2007b). Preliminary evidence of a decline in perfluorooetanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations in American Red Cross blood donors. Chemosphere 68, 105-111.
48. Olsen, G. W., and Zobel, L. R. (2007). Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers. Int. Arch. Occup. Environ. Health. 81, 231-246.
49. Organisation for Economic Co-operation and Development (2002). ENV/JM/RD (2002)17/FINAL: Hazard assessment bf perfluorooctane sulfonate (PFOS) and its salts. Report of the Environment Directorate, Joint Meeting of the Chemicals Committee and the Working Party on Chemicals, Pesticides and Biotechnology, Co-operation on Existing Chemicals. Paris, November 21, 2002.
50. Rosen, M. B., Thibodeaux, J. R.,.Wood, C. R., Zehr, R. D., Schmid, J. E., and Lau, C. (2007). Gene expression profiling in the lung and liver of PFOA-exposed mouse fetuses. Toxicology 239, 15-33.
51. Sakr, C. J., Leonard, R. C., Kreckmann, K.H.; Slade, M.D., and Cullen, M. R. (2007a). Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctonoate. J. Occup. Environ. Med. 49, 872-879.
52. Sakr, C. J., Kreckmann, K.H., Green, J. W., Gillies, P. J., Reynolds, J. L., and Leonard, R. C. (2007b). Cross-Sectional Study of Lipids and Liver Enzymes Related to a Serum Biomarker of Exposure (ammonium perflurooctanote or APFO) as Part of a General Health Survey in a Cohort of Occupationally Exposed Workers. J Occup Environ Med. 49, 1086-1096.
53. Shah, Y. M., Morimura, K., Yang, Q., Tanabe, T., Takagi, M., and Gonzalez, F. J. (2007). Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation. Mol. Cell. Biol. 27, 4238-4247.
54. Taves, D. R. (1968). Evidence that there are two forms of fluoride in human serum. Nature 217, 1050-1051.
55. Thibodeaux, J. R., Hanson, R. G., Rogers, J. M., Grey, B. E., Barbee, B. D., Richards, J. H., Butenhoff, J. L., Stevenson, L. A., and Lau, C. (2003). Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: Maternal and prenatal evaluations. Toxicol. Sci. 74, 369-381. [Erratum to Toxicol. Sci. 2003; 74; 369-381: Toxicol. Sci. 82, 359.]
56. Vanden Heuvel, J. P., Thompson, J. T., Frame, S. R., and Gillies, P. J. (2006). Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: A comparison of human, mouse, and rat peroxisonne proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha. Toxicol. Sci. 92, 476-489.
57. Wolf, C. J., Fenton, S. E., Schmid, J. E., Calafat, A. M., Kuklenyik, Z., Bryant, X. A., Thibodeaux, J., Das, K. P., White, S. S., Lau, C. S., et al. (2007). Developmental toxicity of perfluorooctanoic acid in the CD-1 mouse after cross-foster and restricted gestational exposures. Toxicol. Sci. 95, 462-473.
58. Yang, Q., Xie, Y., and Depierre, J. W. (2000). Effects of peroxisome proliferators on the thymus and spleen of mice. Clin. Exp. Immunol. 122, 219-226.
59. Yang, Q., Abedi-Valugerdi, M., Xie, Y., Zhao, X. Y., Moller, G., Nelson, B. D., and DePierre, J. W. (2002a). Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid. Int. Immunopharmacol. 2 389-397.
60. Yang, Q., Xie, Y., Alexson, S. E., Nelson, B. D., and DePierre, J. W. (2002b). Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice. Biochem. Pharmacol. 63, 1893-1900.